117 related articles for article (PubMed ID: 3784917)
21. Estrogen replacement after menopause. When is it warranted?
Charles AG
Postgrad Med; 1989 Mar; 85(4):99-101, 104. PubMed ID: 2928282
[TBL] [Abstract][Full Text] [Related]
22. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
Riis BJ; Johansen J; Christiansen C
Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
[TBL] [Abstract][Full Text] [Related]
23. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women.
Wen Y; Doyle MC; Norris LA; Sinnott MM; Cooke T; Harrison RF; Feely J
Br J Clin Pharmacol; 1999 Mar; 47(3):315-21. PubMed ID: 10218915
[TBL] [Abstract][Full Text] [Related]
24. Long-term progestogen treatment and bone remodelling in peri-menopausal women: a longitudinal study.
Dequeker J; De Muylder E
Maturitas; 1982 Dec; 4(4):309-13. PubMed ID: 7169964
[TBL] [Abstract][Full Text] [Related]
25. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
Riis BJ; Christiansen C
Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
[TBL] [Abstract][Full Text] [Related]
26. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures.
Cagnacci A; Zanin R; Cannoletta M; Generali M; Caretto S; Volpe A
Fertil Steril; 2007 Dec; 88(6):1603-8. PubMed ID: 17481628
[TBL] [Abstract][Full Text] [Related]
27. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
28. Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta.
Fiet J; Hermano M; Witte J; Villette JM; Haimart M; Gourmel B; Tabuteau F; Rouffy J; Dreux C
Acta Endocrinol (Copenh); 1982 Sep; 101(1):93-7. PubMed ID: 6812348
[TBL] [Abstract][Full Text] [Related]
29. Metabolic effects of oestrogens: impact of the route of administration.
Ho KK; O'Sullivan AJ; Wolthers T; Leung KC
Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
Dobs AS; Nguyen T; Pace C; Roberts CP
J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
[TBL] [Abstract][Full Text] [Related]
31. Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal women.
Isaacs AJ; Havard CW
Clin Endocrinol (Oxf); 1978 Oct; 9(4):297-302. PubMed ID: 719904
[TBL] [Abstract][Full Text] [Related]
32. Role of progestogens in the prevention of breast cancer.
Gambrell RD
Maturitas; 1986 Jul; 8(2):169-76. PubMed ID: 3747850
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of urinary oestrogen assays after the menopause and their potential for screening.
Rae MH; Mole PA; Paterson CR
Clin Chim Acta; 1988 Aug; 176(1):71-81. PubMed ID: 3168295
[TBL] [Abstract][Full Text] [Related]
34. Oestrogen therapy in the peri-menopause: A practical approach.
Haspels AA
Acta Endocrinol Suppl (Copenh); 1980; 233():57-61. PubMed ID: 6996406
[TBL] [Abstract][Full Text] [Related]
35. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
[TBL] [Abstract][Full Text] [Related]
36. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
Reginster JY; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet AN; Franchimont P
Calcif Tissue Int; 1993 Jul; 53(1):13-6. PubMed ID: 8394191
[TBL] [Abstract][Full Text] [Related]
37. [Development of menopause management and menopausal related hormone replacement therapy].
Yu Q
Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):287-90. PubMed ID: 23902813
[No Abstract] [Full Text] [Related]
38. Review of the status of oestrogen replacement therapy.
Bye PG
Postgrad Med J; 1978; 54 Suppl 2():7-10. PubMed ID: 368742
[TBL] [Abstract][Full Text] [Related]
39. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Jensen J; Christiansen C
Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
[TBL] [Abstract][Full Text] [Related]
40. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
Wide L; Naessén T; Eriksson K; Rune C
Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
